Investors are not reacting favorably to the Seattle Genetics’ stage three trial results for its lymphoma treatment.
source CNBC
Seattle Genetics Plunges After Issuing Stage 3 Trial Results
previous post
Investors are not reacting favorably to the Seattle Genetics’ stage three trial results for its lymphoma treatment.
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More